MDA-MB-231 is a triple-negative breast cancer cell line that lacks the expression of estrogen receptor (ER−), progesterone receptor (PR−), and human epidermal growth factor receptor 2 (HER2−). Here, PGR is linked to triple-negative breast carcinoma.